SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to significant premarket gains and news regarding its nasal spray technology, sparking community discussion about potential resistance levels and whether to buy. The stock's volatility, low float, and association with Israeli stocks contribute to the intense speculation, with comparisons being drawn to similar high-flying stocks. Discussions also include potential dilution, short squeezes, and the stock's long-term viability.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation play following Needham's rating update to Hold. Community members are debating the company's growth prospects, share buybacks, and potential for a short squeeze after earnings. Talk centers around agentic AI revenue and the stock's valuation relative to peers in the tech and robotics sectors.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc is trending amid discussions about its strategic partnership with Solvay and its potential role in supplying rare earth materials, particularly Samarium, for magnet production. Community members are weighing the impact of this partnership and the broader implications for U.S. rare earth independence, especially in light of geopolitical tensions and the upcoming Russell 2000 index inclusion.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending after announcing a partnership with Palantir to integrate their AI platforms, with analysts suggesting the company is well-positioned to capitalize on AI demand. The community is discussing the potential impact of this partnership, particularly on Snowflake's data cloud and its competitive positioning against other cloud service providers. Despite a YTD surge, some are questioning the valuation and profitability.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce stock is trending due to its recent revenue forecast and discussions around AI integration, with the community debating the company's future and the potential impact of Agentforce. Despite mixed financial results and concerns about AI disrupting its core business, some analysts maintain a positive outlook. The stock's volatility and leadership are also focal points, with some suggesting a need for fresh perspectives.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

Recent data regarding uniQure's Huntington's disease treatment, AMT-130, has driven considerable discussion, especially after the FDA communicated that current data may not be sufficient for a BLA submission. The community is debating the future of QURE with some concerned about management's decisions and transparency, while others remain optimistic about the drug's potential and possibility of a buyout, citing the significant unmet need for Huntington's treatments. Concerns are circulating around the possibility of further delays and the need for additional trials.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its self-proclaimed viral community and meme-driven approach within the crypto space. Active community members consistently express enthusiasm, focusing on the fun and unique culture surrounding the token. The community emphasizes its organic growth, resilience against negativity (

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors discuss its expansion into Canada and the potential impact on revenue, along with its recent acquisition of YourBio Health. Community members are debating whether these developments will drive the stock price higher or if it will face continued pressure from short sellers. Some see the company as undervalued, while others express concern about its ability to break through resistance levels.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General's recent earnings beat and raised fiscal year guidance have sparked community discussion around the stock's potential. While some investors express frustration with its past performance compared to tech stocks, others point to its value proposition and resilience in a challenging economic environment, especially with strategic initiatives like store remodels and digital upgrades. Broader context includes commentary around consumer spending habits and how tariff impacts could level the playing field for discount retailers.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports ($GENI) is trending amid analyst upgrades and raised price targets, driven by optimism surrounding its expanding data and technology platform. The community is discussing the company's strong positioning in the sports betting industry and potential for increased free cash flow conversion. Investors are also closely watching the upcoming Investor Day for further insights into the company's growth strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curis to Present at Upcoming 30th Annual SNO Meeting

Curis to Present at Upcoming 30th Annual SNO Meeting Curis to Present at Upcoming 30th Annual SNO Meeting PR Newswire LEXINGTON, Mass., Nov. 14, 2025 LEXINGTON, Mass., Nov. 14, 2025 /PRNewswire...

Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of +20.97% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Curis Provides Third Quarter 2025 Business Update

Curis Provides Third Quarter 2025 Business Update Curis Provides Third Quarter 2025 Business Update PR Newswire LEXINGTON, Mass., Nov. 6, 2025 Management to host conference call and webcast today at...

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 Curis to Report Third Quarter 2025 Financial and Operating Results and Host...

Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of +65.83% and +14.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Curis Announces Additional Data from TakeAim Leukemia Study

Curis Announces Additional Data from TakeAim Leukemia Study Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire LEXINGTON, Mass., Dec. 10, 2024 LEXINGTON, Mass., Dec. 10, 2024...

Curis Provides Third Quarter 2024 Business Update

Curis Provides Third Quarter 2024 Business Update Curis Provides Third Quarter 2024 Business Update PR Newswire LEXINGTON, Mass., Nov. 14, 2024 Management to host conference call today at 8:30 a.m...

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 Curis to Report Third Quarter 2024 Financial and Operating Results and...

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement PR Newswire LEXINGTON, Mass., Oct...

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer PR Newswire LEXINGTON, Mass., Sept. 23, 2024 Symposium hosted by Eric S. Winer...

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Current Price	$1.25
Prev Close	$1.20
Open	$1.22
Dividend Yield	0.00%
50-Day Moving Average	$1.44
Beta	0.86
Avg. Volume	102,865.21
PE Ratio	-0.34

52-Week High	$4.50
52-Week Low	$1.02
Market Capitalization	$16.16M
EPS (Annual)	-$6.88
Price to Book	-1.08
Revenue Per Employee	$320,823.53
Enterprise Value/EBITDA	N/A

CRIS
Curis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRIS News

CRISCuris Inc